Cargando…
Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists
Targeted molecular treatments have changed the way non-small cell lung cancer (NSCLC) is managed. Epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), v-raf murine sarcoma viral oncogene homolog B1 (BRAF), and c-ros oncogene 1 (ROS1) mutations are now used to guide specific ant...
Autores principales: | Bui, Kim Tam, Cooper, Wendy A., Kao, Steven, Boyer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111731/ https://www.ncbi.nlm.nih.gov/pubmed/30065223 http://dx.doi.org/10.3390/jcm7080192 |
Ejemplares similares
-
An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer
por: Ahmadzada, Tamkin, et al.
Publicado: (2018) -
Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
por: Barnet, Megan B., et al.
Publicado: (2018) -
Oncologist uptake of comprehensive genomic profile guided targeted therapy
por: Nesline, Mary K., et al.
Publicado: (2019) -
An update on clinical oncology for the non-oncologist
por: Kaliks, Rafael Aliosha
Publicado: (2016) -
What we know about surgical therapy in early-stage non-small-cell lung cancer: a guide for the medical oncologist
por: Ghanem, Sassine, et al.
Publicado: (2017)